Abstract:A Disintegrin and Metalloproteinase 12 (ADAM12) is expressed significantly higher in multiple tumors than in normal tissues and has been used as a prognostic marker for the evaluation of cancer progression. Although several ADAM12 substrates have been identified biochemically and its proteolytic function has been explored, the upstream regulators and the interacting proteins have not been systematically investigated. Here, we use immunoprecipitation and mass spectrometry (MS)-based quantitative proteomic approaches to identify 28 interacting partners for the long form of ADAM12 (ADAM12-L) in HeLa cells. Proteins that regulate cell proliferation, invasion, and epithelial to mesenchymal transition are among the identified ADAM12-interacting proteins. Further biochemical experiments discover that the protein level and the stability of ADAM12 are upregulated by one of its interacting proteins, myoferlin. In addition, myoferlin also increases the proteolytic activity of ADAM12, leading to the reduction of an ADAM12 substrate, E-cadherin. This result implies that ADAM12 and its interacting proteins might converge to certain signaling pathways in the regulation of cancer cell progression. The information obtained here might be useful in the development of new strategies for modulating cell proliferation and invasion involved in the regulation between ADAM12 and its interacting partners. MS data are available via ProteomeXchange with identifier PXD003560.Biological significance: Regulation of the proliferation and invasion of cancer cells is important in cancer treatment. ADAM12 has been found to play important roles in regulating these processes and identification of its interacting partners will improve our understanding of its biological functions and provide basis for functional modulation. Through mass spectrometry-based quantitative proteomic approaches, we identify the interacting partners for ADAM12 in a human cancer cell line and find many proteins that are involved in the proliferation and invasion of cancer cells. A novel regulator, myoferlin, of ADAM12 is discovered and this protein increases ADAM12 expression level, stability, and its enzymatic activity, leading to the reduction of its substrate, E-cadherin, which plays important roles in the regulation of cell adhesion and tumor metastasis. This result provides a connection for two highly expressed proteins in cancer cells and may shed light on the regulation of their biological functions in cancer progression. (C) 2016 Elsevier B.V. All rights reserved.

ADAM15 Suppresses Cell Motility by Driving Integrin Α5β1 Cell Surface Expression Via Erk Inactivation

Adam10 Promotes Pituitary Adenoma Cell Migration By Regulating Cleavage Of Cd44 And L1

Integrin Α3/α6 and Αv Are Implicated in ADAM15-activated FAK and EGFR Signalling Pathway Individually and Promote Non-Small-cell Lung Cancer Progression

ADAM17 Promotes Epithelial-Mesenchymal Transition Via TGF-β/Smad Pathway in Gastric Carcinoma Cells

Loss of ADAM9 expression impairs β1 integrin endocytosis, focal adhesion formation and cancer cell migration

ADAM15 in Fibroblasts: Improving the Matrix Remodeling by Blocking the Action of Transforming Growth Factor-β1

ADAMTS-1 and syndecan-4 intersect in the regulation of cell migration and angiogenesis

ADAM22 Plays an Important Role in Cell Adhesion and Spreading with the Assistance of 14-3-3.

Overexpression of ADAMTS5 Can Regulate the Migration and Invasion of Non-Small Cell Lung Cancer

Metalloprotease ADAMTS-1 decreases cell migration and invasion modulating the spatiotemporal dynamics of Cdc42 activity

A Disintegrin and Metalloprotease 22 Accelerates Neointima Formation by Activating ERK Signaling

The Interaction Between ADAM 22 and 14-3-3zeta: Regulation of Cell Adhesion and Spreading.

ADAM15 Correlates with Prognosis, Immune Infiltration and Apoptosis in Hepatocellular Carcinoma

Quantitative Proteomics Identifies Myoferlin As a Novel Regulator of A Disintegrin and Metalloproteinase 12 in HeLa Cells.

Epigenetic silencing of ADAMTS5 is associated with increased invasiveness and poor survival in patients with colorectal cancer

ADAM17 promotes colorectal cancer migration and invasion by regulating the TGF-β/Smad signaling pathway

A Disintegrin and Metalloprotease 10 Expressions Modulate Potential Metastatic and Thrombus Formation in Pancreatic Carcinoma

ADAM33 Silencing Inhibits Vascular Smooth Muscle Cell Migration and Regulates Cytokine Secretion in Airway Vascular Remodeling via the PI3K/AKT/mTOR Pathway

Regulation of Adhesion of Aml14.3d10 Cells by Surface Clustering of Beta(2)-Integrin Caused by Erk-Independent Activation of Cpla(2)

Expression levels of the metalloproteinase ADAM8 critically regulate proliferation, migration and malignant signalling events in hepatoma cells

ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway